BioSpace News Archive

As robots gain attention as weapons to fight the spread of Coronavirus globally, Blue Ocean Robotics announced that it has been included in Robotics Business Review’s list of the 50 most influential robotics companies in the world (RBR50) for its UVD Robots

Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and other neurodegenerative diseases, today announced it has completed enrollment in the Phase II PEGASUS trial assessing AMX0035 in individuals with Alzheimer’s disease. Amylyx completed

Eye Care Professionals in Zambia to Receive the Inaugural Remote Training via Award-Winning Telemedicine Platform Cybersight amid Coronavirus Pandemic

The SGLT2 inhibitor dapagliflozin, when used in patients with heart failure, provided a benefit in preventing type 2 diabetes (T2D), according to the study, “Effect of Dapagliflozin on the Incidence of Diabetes: A Prespecified Exploratory Analysis from DAPA-HF,” presented today at the American Diabetes Association’s® (ADA’s) 80th Virtual Scientific Sessions.

BioWave is building on its recent national TV advertising campaign and increasing the national awareness of the popular BioWaveGO through a partnership with PGA Tour Champion Rocco Mediate that will help amplify the GO’s unique pain relief pedigree and patented technology.

Technique for Inserting Somatic Nuclei into Stem Cells Recognized as Best Paper by Biomicrofluidics

7 Hills Pharma, a clinical-stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases, highlighted its integrin platform technology for improving immunotherapies in a video presentation at BIO Digital 2020 featuring President and CEO Upendra Marathi

Rite Aid Corporation said that it will release financial results for its Fiscal 2021 First Quarter, which ended May 30, 2020, on Thursday, June 25, 2020.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced safety and tolerability data at one year from four Duchenne muscular

Trawick International (TI) today announces new strategic partnerships with Crum & Forster SPC and On Call International to further optimize the customer experience.